Iggantibody Type Is Considered To Be Neutralizing

Interferon alpha Neutralizing Antibody
20-abx137013
  • EUR 427.20
  • EUR 627.60
  • 0.5 mg
  • 1 mg

Igg Antibody Laboratories manufactures the iggantibody type is considered to be neutralizing reagents distributed by Genprice. The Iggantibody Type Is Considered To Be Neutralizing reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact igg antibody. Other Iggantibody products are available in stock. Specificity: Iggantibody Category: Type Group: Is Considered

JBS True Blue
300 µl
EUR 16
Description: JBS True Blue

Cytomegalovirus gB Late Neutralizing Antigen (CMV-LA gB Neutralizing) Antibody
0.2 mg
EUR 678

Neutralizing Buffer 100gm
EACH
EUR 85.2

Cytomegalovirus gB Late Neutralizing Antigen (CMV-LA gB Neutralizing) Antibody (FITC)
0.1 mg
EUR 610.8

Anti-PD-1 Neutralizing Antibody
100 µg
EUR 465
Description: Neutralizing recombinant murine/human chimeric antibody recognizing the PD-L1/PD-L2 binding region of human PD-1. This antibody does not cross-react with mouse PD-1, but does cross-react with monkey (M. fascicularis) PD-1. It has not been tested with other species.

Anti-CTLA4 (CD152) Neutralizing Antibody
100 µg
EUR 490
Description: Neutralizing recombinant human monoclonal antibody recognizing the extracellular domain of CTLA4 and blocking binding of CTLA4 to B7.1 and B7.2. This antibody recognizes human CTLA4 but does not bind to murine CTLA4. This antibody has not been tested for cross-reactivity with other species.

Anti-β-Amyloid Neutralizing Antibody
100 µg
EUR 465
Description: Purified, recombinant, humanized Anti-β-amyloid (IgG1) antibody, expressed in HEK293 cells. This antibody reacts with human β-amyloid and has not been tested for cross-reactivity with other species.

Is Considered information

Anti-IL-17A Neutralizing Antibody
91015 100 µg
EUR 490
Description: Neutralizing recombinant human_x000D_chimeric antibody recognizing human IL-17A._x000D_This antibody has not been tested for crossreactivity_x000D_with other species.

Horse Anti-Rabies Virus IgG (Fab2), neutralizing
RBV16-Fab2 100 ul
EUR 534

Interferon alpha Neutralizing Antibody
20-abx137013
  • EUR 427.20
  • EUR 627.60
  • 0.5 mg
  • 1 mg

Anti-CTLA4 (CD152) Neutralizing Antibody
71212 100 µg
EUR 490
Description: Neutralizing recombinant human monoclonal antibody recognizing the extracellular domain of CTLA4 and blocking binding of CTLA4 to B7.1 and B7.2. This antibody recognizes human CTLA4 but does not bind to murine CTLA4. This antibody has not been tested for cross-reactivity with other species.

Anti-β-Amyloid Neutralizing Antibody
71223 100 µg
EUR 465
Description: Purified, recombinant, humanized Anti-β-amyloid (IgG1) antibody, expressed in HEK293 cells. This antibody reacts with human β-amyloid and has not been tested for cross-reactivity with other species.

Anti-PD-L1 (CD274) Neutralizing Antibody
71213 100 µg
EUR 505
Description: Neutralizing recombinant chimeric murine/human monoclonal antibody recognizing the extracellular domain of PD-L1 and blocking the binding of PD-L1 to PD-1. This antibody has been shown to cross-react with mouse PD-L1. No other species have been tested.

Anti-PCSK9 Neutralizing Antibody, (IgG1) Biotin-labeled
71216 50 µg
EUR 530
Description: Purified recombinant human_x000D_anti-PCSK9 (IgG1) antibody with a C-terminal_x000D_Avi-tag, expressed in HEK293 cells. Purified_x000D_antibody was enzymatically biotinylated using_x000D_AviTag™ technology. This antibody reacts with_x000D_human PCSK9 and has not been tested for_x000D_cross-reactivity with other species.

Anti-PCSK9 Neutralizing Antibody, (IgG4) Biotin-labeled
71217 50 µg
EUR 515
Description: Purified recombinant human_x000D_anti-PCSK9 (IgG4) antibody with a C-terminal_x000D_Avi-tag, expressed in HEK293 cells. Purified_x000D_antibody was enzymatically biotinylated using_x000D_AviTag™ technology. This protein reacts with_x000D_human PCSK9 and has not been tested for_x000D_cross-reactivity with other species.

Monoclonal NGF/proNGF Neutralizing Antibody Antibody
AMM06679G 0.05mg
EUR 633.6
Description: A Monoclonal antibody against Human NGF/proNGF Neutralizing. The antibodies are raised in Mouse. This antibody is applicable in E

Anti-NGF (Nerve Growth Factor) Neutralizing Antibody
100436-1 50 µg
EUR 355
Description: Anti-NGF Neutralizing Recombinant Human antibody. This_x000D_ antibody has not been tested for crossreactivity_x000D_ with other species.

Anti-NGF (Nerve Growth Factor) Neutralizing Antibody
100436-2 100 µg
EUR 490
Description: Anti-NGF Neutralizing Recombinant Human antibody. This_x000D_ antibody has not been tested for crossreactivity_x000D_ with other species.

Anti-PD-1 Neutralizing Antibody, Biotin-labeled
71215 100 µg
EUR 510
Description: Purified, recombinant, human anti-PD-1 (IgG1) antibody with C-terminal Avitag, expressed in HEK293 cells. Purified antibody was enzymatically biotinylated using Avitag™ technology. This antibody does not cross-react with mouse PD-1, but does cross-react with monkey (M. fascicularis) PD-1. It has not been tested with other species.

Anti-PD-L1 Neutralizing Antibody, Biotin-labeled
71214 100 µg
EUR 510
Description: Purified, recombinant, chimeric murine/human anti-PD-L1 (IgG1) antibody with C-terminal Avi-tag, expressed in HEK293 cells. Purified antibody was enzymatically biotinylated using Avitag™ technology. This antibody reacts with human PD-L1 and cross-reacts with mouse PD-L1. It has not been tested for cross-reactivity with other species.

SARS-CoV-2 Neutralizing Monoclonal Antibody [DA0002]
A73683-100 100 ul
EUR 506

Spike Neutralizing Antibody (Clone G10xA1) (SARS-CoV-2)
101326 100 µg
EUR 600
Description: This monoclonal antibody recognizes the SARS-CoV-2 Spike RBD (B.1.1.529, Omicron Variant) protein and neutralizes its interaction with ACE2 [Table of Variants]. The human ACE2 receptor is found on the surface of type I and II pneumocytes, endothelial cells, and ciliated bronchial epithelial cells. ACE2 is known to mediate COVID-19 infection through direct binding of the SARS-CoV-2 Spike protein. This neutralizing antibody has been functionally tested using the Spike S1 RBD (B.1.1.529, Omicron Variant) (SARS-CoV-2):ACE2 Inhibitor Screening Colorimetric Assay Kit (BPS Bioscience #78339).

Spike Neutralizing Antibody (Clone G10xA5) (SARS-CoV-2)
101327 100 µg
EUR 600
Description: This monoclonal antibody recognizes the SARS-CoV-2 Spike RBD (B.1.1.529, Omicron Variant) protein and neutralizes its interaction with ACE2 [Table of Variants]. The human ACE2 receptor is found on the surface of type I and II pneumocytes, endothelial cells, and ciliated bronchial epithelial cells. ACE2 is known to mediate COVID-19 infection through direct binding of the SARS-CoV-2 Spike protein. This neutralizing antibody has been functionally tested using the Spike S1 RBD (B.1.1.529, Omicron Variant) (SARS-CoV-2): ACE2 Inhibitor Screening Colorimetric Assay Kit (BPS Bioscience, #78339).

Goat Anti-Human Respiratory Syncytial Virus (RSV) IgG, neutralizing
RSV12-S 100 ul
EUR 548.4